SPONSOR
Zhongda Hospital
Total Trials
4
Recruiting
4
Phases
N/A
Conditions studied: Hepatocellular CarcinomaUnresectable Hepatocellular CarcinomaColorectal Cancer MetastaticSedationMechanical Ventilation
Zhongda Hospital is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Hepatocellular Carcinoma, Unresectable Hepatocellular Carcinoma, Colorectal Cancer Metastatic, Sedation.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Zhongda Hospital
How many clinical trials has Zhongda Hospital sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Zhongda Hospital, of which 4 are actively recruiting participants. These trials cover conditions including Hepatocellular Carcinoma, Unresectable Hepatocellular Carcinoma, Colorectal Cancer Metastatic. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Zhongda Hospital research focus on?
Zhongda Hospital clinical trials span Hepatocellular Carcinoma, Unresectable Hepatocellular Carcinoma, Colorectal Cancer Metastatic, Sedation, Mechanical Ventilation. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Zhongda Hospital clinical trial?
To participate in a Zhongda Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Zhongda Hospital trials with current recruitment status updated daily.
Clinical Trials by Zhongda Hospital
NCT06669377
Recruiting
TACE Combined With ICIs Plus MTT After 125I Irradiation Stent Placement in HCC With Main PVTT.
Hepatocellular Carcinoma
NCT06909708
Recruiting
SIRT Versus cTACE for Unresectable HCC (CHANCE2506)
Unresectable Hepatocellular Carcinoma
NCT06447727
Recruiting
Efficacy and Safety of 90Y Microsphere Combined With FOLFIRI and Bevacizumab in Second-line Treatment of CRLM
Colorectal Cancer Metastatic
NCT06538883
Recruiting
Sedation in ICU Patients With Mechanical Ventilation
Sedation
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology